Fundamentals of Aerospace Medicine: Cosmic Radiation by Bagshaw, Michael & Cucionotta, Francis A.
 FUNDAMENTALS OF AEROSPACE MEDICINE 
 
COSMIC RADIATION 
 
Professor Michael Bagshaw 
King’s College London, School of Biomedical and Health Sciences 
 
Dr Francis A Cucinotta 
NASA, Lyndon B. Johnson Space Center 
 
Introduction 
Cosmic rays were discovered in 1911 by the Austrian physicist, Victor Hess 
The planet earth is continuously bathed in high-energy galactic cosmic 
ionising radiation (GCR), emanating from outside the solar system, and 
sporadically exposed to bursts of energetic particles from the sun referred to 
as solar particle events (SPEs). 
The main source of GCR is believed to be supernovae (exploding stars), while 
occasionally a disturbance in the sun's atmosphere (solar flare or coronal 
mass ejection) leads to a surge of radiation particles with sufficient energy to 
penetrate the earth's magnetic field and enter the atmosphere. 
The inhabitants of planet earth gain protection from the effects of cosmic 
radiation from the earth’s magnetic field and the atmosphere, as well as from 
the sun's magnetic field and solar wind. These protective effects extend to the 
occupants of aircraft flying within the earth’s atmosphere, although the effects 
can be complex for aircraft flying at high altitudes and high latitudes. 
Travellers in space do not have the benefit of this protection and are exposed 
to an ionising radiation field very different in magnitude and quality from the 
exposure of individuals flying in commercial airliners. The higher amounts and 
distinct types of radiation qualities in space lead to a large need for 
understanding the biological effects of space radiation.  
It is recognised that although there are many overlaps between the aviation 
and the space environments, there are large differences in radiation 
dosimetry, risks and protection for airline crew members, passengers and 
astronauts. These differences impact the application of radiation protection 
principles of risk justification, limitation, and the principle of as low as 
reasonably achievable (ALARA). This chapter accordingly is divided into three 
major sections, the first dealing with the basic physics and health risks, the 
second with the commercial airline experience, and the third with the aspects 
of cosmic radiation appertaining to space travel including future 
considerations. 
https://ntrs.nasa.gov/search.jsp?R=20070028831 2019-08-30T01:33:53+00:00Z
 Part One 
 
Ionising Radiation 
Ionising radiation refers to subatomic particles that, on interacting with an 
atom, can directly or indirectly cause the atom to lose an electron or break 
apart its nucleus. It is when these events occur in body tissue that health 
effects may result if the human body's self-repair mechanism fails. 
Ionising radiation types and their properties are shown in Table 1. 
 
Table 1. 
Radiation 
Type 
 
Consists of 
 
Range in 
air 
 
Range in human 
tissue 
 
Hazard site 
(see note) 
 
beta 
particles 
 
an electron 
 
several 
metres 
 
few mm 
 
internal + 
external 
 
gamma rays 
 
electromagnetic ray 
 
many 
metres 
 
many cm 
 
internal + 
external 
 
X rays 
 
electromagnetic ray 
 
many 
metres 
 
many cm 
 
external 
 
protons Free proton few to 
many cm 
few to many cm external 
neutrons 
 
free neutrons 
 
many 
metres 
 
many cm 
 
external 
 
alpha 
particles 
2 protons + 2 
neutrons (Helium) 
 
few cm 
 
cannot penetrate 
skin 
 
internal 
 
high charge 
and energy 
(HZE) 
Nuclei  
Nuclei of atoms with 
n- neutrons and z-
protons 
Few to 
many cm 
Few to many cm external 
 
Note: The hazard site refers to whether the radiation type exerts its effect only 
on ingestion or inhalation (internal), or whether it can penetrate the human 
body (external). 
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Outside the earth's atmosphere, GCR consists mostly of fast-moving protons 
(hydrogen nuclei), alpha particles (helium particles), and high charge and 
energy (HZE) nuclei ranging from lithium to uranium. GCR is 98% atomic 
nuclei and 2% electrons (44). Of the energetic nuclei, 87% are protons, 12% 
are helium ions and 1% are heavier ions. The energy of GCR is expressed as 
megaelectron volt per atomic mass unit (1 MeV/u = 9.64853336 x 1013 m2/s2). 
The energies range from a few MeV/u to more than 10,000 MeV/u peaking 
near 1,000 MeV/u. The higher energy ions move close to the speed of light.   
 
As charged particles pass through shielding or the atmosphere, and tissue 
they lose energy and undergo nuclear interactions. Energy loss is caused by 
electromagnetic interactions transferring energy to electrons leading to 
ionisation and excitation. The rate of energy loss increases rapidly with 
increasing charge of the particle and decreasing speed (56). The distance 
travelled depends on the energy, and massive particles are more penetrating 
than lighter particles of the same charge and speed. Uncharged particles 
have longer free paths and, for neutrons, larger energy transfers per event 
result in energy losses which appear as isolated occurrences along the 
particle's path. 
 
Nuclear interactions produce lower charge and mass nuclei from a primary 
GCR nucleus and also secondary radiation from the material being hit (59). 
The mean free path for nuclear collision is on the order of 10 cm and after 
several mean free paths the primary GCR heavy ions are converted largely 
into protons and neutrons. On entering the earth's atmosphere, the particles 
collide with the nuclei of nitrogen, oxygen and other atmospheric atoms, 
generating additional (secondary) ionising radiation particles. At normal 
commercial aircraft flight altitudes this GCR consists mainly of neutrons, 
protons, electrons, positrons and photons. 
 
Diagram 1 illustrates the production of secondary particles as a primary 
particle penetrates the earth’s atmosphere and interacts with an atmospheric 
nucleus. 
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Terrestrial Protection from GCR 
Protection from cosmic radiation for the earth's inhabitants is provided by 
three variables: 
1. the sun's magnetic field and solar wind (solar cycle) 
2. the earth's magnetic field (latitude) 
3. the earth's atmosphere (altitude). 
 
1. The sun has a varying magnetic field with a basic dipole component which 
reverses direction approximately every 11 years. Recently solar maximum 
period peaked around 2000-02 and the next one is expected around 2011. 
Near the reversal, at 'solar minimum' (around 2006 in the current cycle), there 
are few sunspots and the magnetic field extending throughout the solar 
system is relatively weak and smooth. At solar maximum there are many 
sunspots and other manifestations of magnetic turbulence, and the plasma of 
protons and electrons ejected from the sun (the solar wind) carries a relatively 
strong and convoluted magnetic field with it outward through the solar system 
(19). 
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When the solar magnetic field is stronger, the paths of the electrically charged 
ions are deflected further and less GCR reaches the earth. Thus solar 
maximum causes a radiation minimum and, conversely, solar minimum is the 
time of radiation maximum. The effect of this depends on the other two 
variables, altitude and geomagnetic latitude. At the altitudes flown by 
commercial jet aircraft and at polar latitudes, the ratio for GCR at solar 
minimum to that at solar maximum is in the region of 1.2 to 2 and increases 
with altitude (4, 5). 
 
2. The earth's magnetic field has a larger effect than the sun's magnetic field 
on cosmic radiation approaching the atmosphere.  
Near the equator the geomagnetic field is almost parallel to the earth's 
surface. Near the magnetic poles the geomagnetic field is nearly vertical and 
the maximum number of primary cosmic rays can reach the atmosphere. At 
extremes of latitude, there is no further increase in GCR flux with increasing 
latitude and this is known as the polar plateau.  
As a result, cosmic radiation levels are higher in polar regions and decline 
towards the equator, the size of this effect depending upon altitude and the 
point in the solar cycle. At the altitudes flown by commercial jet aircraft, at 
solar minimum, GCR is 2.5 to 5 times more intense in polar regions than near 
the equator, with larger latitude dependence as altitude increases (55). 
 
3. Life on earth is shielded from cosmic radiation by the atmosphere. 
The charged cosmic radiation particles lose energy as they penetrate the 
atmosphere by ionising the atoms and molecules of the air (releasing 
electrons). The particles also collide with the atomic nuclei of nitrogen, oxygen 
and other atmospheric constituents.  
The ambient radiation increases with altitude by approximately 15% for each 
increase of around 2,000 ft (~600 m) (dependent on latitude), with certain 
secondary particles reaching a maximum at around 65,000 feet (20 km) (the 
Pfotzer maximum). Primary heavy ions and secondary fragments become 
important above this point. 
As well as providing shielding from GCR, the atmosphere contributes different 
components to the radiation flux as a function of atmospheric depth. 
Accordingly the potential biological effects of cosmic radiation on aircraft 
occupants are directly altitude dependent. 
 
Dose rate increases with both altitude and latitude. The effect of increasing 
latitude at a constant altitude is greater than that of increasing altitude at a 
constant latitude. 
Figure 1 is taken from Goldhagen (2000) (19), reproduced from the journal 
Health Physics with permission from the Health Physics Society and the 
National Council on Radiation Protection and Measurements. It shows the 
calculated effective dose rate from each of the secondary components 
produced by GCR (and the total effective dose) as a function of altitude for a 
 5
location at the edge of the polar plateau during solar minimum (radiation 
maximum). 
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It can be seen that the total effective dose rate at 30,000 ft is about 90 times 
the rate at sea level. It increases by a factor of 2 between 30,000 ft and 
40,000 ft, and by another factor of 2 between 40,000 ft and 65,000 ft. It should 
be noted that at all altitudes from 10,000 ft to over 80,000 ft (3 to 25 km) 
neutrons are the dominant component. They are less dominant at lower 
latitudes, but still contribute 40 to 65% of the total dose equivalent rate. 
 
Solar Flares 
Occasionally a disturbance in the sun's atmosphere, known as a solar particle 
event (SPE), leads to a surge of radiation particles. These are produced by 
sudden sporadic releases of energy in the solar atmosphere (solar flares) and 
by coronal mass ejections (CMEs), and are usually of insufficient energy to 
contribute to the radiation field at aviation altitudes. However, on occasions 
proton particles are produced with sufficient energy to penetrate the earth's 
magnetic field and enter the atmosphere. These particles interact with air 
atoms in the same way as GCR particles. Such events are comparatively 
short lived and vary with the 11-year solar cycle, being more frequent at solar 
maximum. 
Long distance radio communications are sometimes disrupted because of 
increased ionisation of the earth’s upper atmosphere by X-rays, protons or 
ultra-violet radiation from the sun. This can occur in the absence of excessive 
ionising radiation levels at commercial flight altitudes. Similarly the Aurorae 
Borealis and Australis (northern and southern lights), while resulting from the 
interaction of charged particles with air in the upper atmosphere, are not an 
indication of increased ionising radiation levels at flight altitudes. 
When primary solar particle energies are sufficient to produce secondary 
particles detected at ground level by neutron monitors, this is known as 
ground level enhancement (GLE). GLEs are rare, averaging about one per 
year grouped around solar maximum, and the spectrum varies between 
events (34). Any rise in dose rates associated with an event is rapid, usually 
taking place in minutes. The duration may be hours to several days. 
The strong magnetic disturbance associated with SPEs can lead to significant 
decreases in GCR dose rate over many hours as a result of the enhanced 
solar wind (Forbush decrease). The disturbance to the geomagnetic field can 
allow easier access to cosmic rays and solar particles. This can give 
significant increases at lower latitudes particularly for SPEs. Thus the 
combined effect of an SPE may be a net decrease or increase in radiation 
dose, and further work is needed to understand the contribution of SPEs to 
dose. Prediction of which SPEs will give rise to significant increases in 
radiation dose rates at commercial aircraft operating altitudes is not currently 
possible, and work continues with this aspect of space weather. 
GLEs have been recorded and analysed since 1942, and are numbered 
sequentially (12). With the exception of GLE5 (February 1956), of the 64 
GLEs observed up to 2003, none has presented any risk of attaining an 
annual dose of 1 mSv (the International Commission on Radiological 
Protection [ICRP] recommended public exposure limit) (29). For GLE60, which 
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occurred in April 2001, the total contribution to radiation dose from the SPE 
was measured as 20 μSv (51) 
GLE42, which occurred in September 1989, was the most intense observed 
since that of 1956 (GLE5) with a recorded magnitude of 252%. However this 
represented about one month of GCR exposure only, which would not have 
given an annual dose in excess of 1mSv (30). Concorde supersonic transport 
aircraft of British Airways were flying during this solar event and the on-board 
monitoring equipment did not activate a radiation warning alert, which is 
triggered at 0.5mSv per hour. However it should be cautioned that the latitude 
effect exceeds the altitude effect for SPEs and Concorde did not reach very 
high magnetic latitudes. 
It has been reported (29) that a number of airlines have changed flight plans 
to avoid high geomagnetic latitudes during periods of predicted solar flare 
ground level events, with significant cost and delays to service. Data indicate 
that these actions were unnecessary in terms of radiation dose protection. 
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Part Two 
 
Biological Effects of Ionising Radiation 
Very high levels of ionising radiation, such as that from a nuclear explosion, 
will cause severe cell damage or cell death. Adverse health impacts include  
early death, within days or a few weeks, as a result of acute exposure; or to 
longer-term consequences such as the development of cancer, or to genetic 
mal-development as a result of damage to the reproductive cells. It is more 
difficult to predict the effects of low-level doses of ionising radiation such as 
cosmic radiation or medical X-rays because of the individual variability in the 
body’s self-repair process. Indeed, several health effects have been 
suggested at low doses and dose-rates, including that the effect of radiation 
on human health is not linear, but is either a J-shaped curve with exposure 
being beneficial at low doses (27, 53); or in contrast is increased due to non-
targeted effects where cells not directly traversed by radiation tracks are 
responsible for malignancy (60, 61).  
Biological effectiveness depends on the spatial distribution of the energy 
imparted and the density of the ionisations per unit path length of the ionising 
particles. The energy loss per unit path length of a charged particle is referred 
to as the ‘stopping power’, while the energy deposited is referred to as 'linear 
energy transfer' (LET). 
The ionisation process in living tissues consists of atomic and molecular 
excitations, and ejecting bound electrons from the cellular molecules, leaving 
behind chemically active radicals which are the source of adverse changes. 
Many of the radicals resulting from radiation injury are similar to those 
produced in normal metabolic processes, for which the cell has developed 
recovery mechanisms needed for long term survival (7). The number of 
ionisation events per particle passage is related to the physical processes by 
which particle kinetic energy is transferred to the cellular bound electrons (56). 
The rate at which ions produce electrons in isolated cells is important, since 
repair of a single event is relatively efficient unless many events occur within 
the repair period (53).   
The substantive target of radiation injury is considered to be the DNA 
structure which may be changed or injured directly by a passing ionising 
particle (56).  DNA damages consists of simple types with a single base 
damage or break in the DNA sugar-phosphate backbone, termed a single 
strand break, to complex DNA damages where two or more damages occur in 
a single helical turn of DNA. The spectrum of DNA damages shifts from 
simple to more complex as the LET is increased (62). Double strand breaks 
(DSB), defined as one or more breaks on opposing sides of the DNA sugar-
phosphate backbone within 20 base pairs of each other, are expected to be 
the most detrimental form of DNA damage leading to various forms of 
mutation including gene deletion and chromosomal aberrations. For high LET 
radiation most DSB are highly complex involving base damage and other 
breaks near a DSB. 
The ability of the cell to repair the effects of ionisation depends on the class of 
DNA lesion (simple or complex) and in part on the number of such events 
occurring within the cell from the passage of a single particle, and the rate at 
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which such passages occur. There are two major pathways of DSB repair in 
vertebrae (63): 1) Non-homologous end-joining (NHEJ), and 2) homologous 
recombination (HR). NHEJ is an error-prone form of repair and is dominant in 
the pre-replication phase of the cell cycle and in resting cells. This process 
involves removal of damage regions near the initial break and ligation of the 
remaining DNA ends. HR is a high fidelity form of DNA damage repair, acting 
during DNA replication and mitosis, and requires a sister chromatid to act as a 
template for the synthesis of DNA during repair.   
In recent years, there has been increased focus on non-DNA targets for 
harmful biological effects of radiation (60, 61). These include oxidative 
damage in the cytoplasm and mitochondria, and aberrant cell signalling 
processes that disrupt normal cellular processes such as the control of 
cellular growth factors, the tissue micro-environment, and DNA replication. 
These so-called non-targeted effects can be both mutagenic and 
carcinogenic.  
 
Chromosome Aberrations 
Tissue cells may be damaged by physical agents such as heat, cold, vibration 
and radiation. Throughout life there is a continuous ongoing cycle of cell 
damage and repair utilising the body’s self-repair mechanism. During the 
repair process, gene translocation and other chromosome aberrations may 
occur. 
A number of studies have identified an increased rate of unstable 
chromosome aberrations such as dicentrics and rings in flight crew members, 
and related these to cosmic radiation exposure (21, 46, 47). Nicholas et al 
note that unstable aberrations decrease with time and thus do not serve as 
good indicators of cumulative exposure to GCR. They postulate that structural 
chromosome aberrations such as translocations may be a better marker since 
they are relatively stable with time since exposure (35). 
The Nicholas et al study showed that the mean number of translocations per 
cell was significantly higher among the airline pilots studied than among the 
controls. However, within the radiation exposure range encountered in the 
study, observed values among the pilots did not follow the dose-response 
pattern expected based on available models for chronic low dose radiation 
exposure. 
This study fails to determine the role of radiation in the induction of 
translocations. There is so far no epidemiological evidence to link these 
aberrations with the development of cancers. 
Studies of chromosome aberrations with high LET radiation, including heavy 
ions, show that the complexity of chromosome aberrations also increases with 
LET (64). These studies are made using multi-colour fluorescence in-situ 
hybridization (FISH), where chromosome specific probes are used to label 
individual chromosomes, and aberrations between 2 or more chromosomes 
then observed after irradiation as illustrated in Figure 3. The number of 
chromosomes involved in chromosomal aberrations appears to increase with 
the LET of the radiation field. George et al. (65) reported the number and 
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types of chromosomal aberrations in astronauts on the International Space 
Station.  
 
Figure 2. Observation of chromosomal aberrations in human lymphocyte cells 
exposed to 300 mGy of gamma-rays or 1 GeV/u Iron ions (64).  
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The biological effect of ionising radiation depends upon whether it is high- or 
low-LET. Early studies of the effect of identical doses of different types of 
radiation on biological systems showed that they produced different amounts 
of damage. This led to the concept of ‘relative biological effectiveness’ (RBE), 
which is defined as the ratio of a dose of a particular type of radiation to the 
dose of gamma-rays or X-rays that yield the same biological end point. 
The dose equivalent to the tissue (DE) is the product of the absorbed dose 
(D) and the quality factor (Q or QF), Q being dependent upon LET. The 
numerical value of Q depends not only upon appropriate biological data, but 
also on the judgment of the ICRP. It establishes the value of the absorbed 
dose of any radiation that engenders the same risk as a given absorbed dose 
of a reference radiation (24). The radiation weighting factor (WR) takes 
account of the quality factor, and recommendations are published from time to 
time by the ICRP (24). 
Low-LET radiation, all with a weighting factor of 1, includes photons, X and 
gamma rays, as well as electrons and muons. Electrons are the low-LET 
radiation of prime concern at aircraft operating altitudes. 
Neutrons, alpha particles, fission fragments and heavy nuclei are classified as 
high-LET, neutrons providing about half the effective dose at high altitudes.   
At all altitudes from 10,000 ft to over 80,000 ft (3 to 25 km) neutrons are the 
dominant component of the cosmic radiation field. They are less dominant at 
lower latitudes, but still contribute 40 to 65% of the total dose equivalent rate. 
Because neutron interactions produce low-energy ions, neutron radiation is 
more effective in inducing biological damage than gamma radiation. However, 
there are no adequate epidemiological data to evaluate to what extent 
neutrons are carcinogenic to humans (23).  
 
The current weighting factors are shown in Table 2. 
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Table 2.  
Type & energy range of incident radiation 
 
Weighting 
factor 
 
Photons (all energies) 
 
1 
 
Electrons and muons (all energies) 
 
1 
 
Protons (incident) 
 
5 (but see text) 
 
Neutrons <10 keV 
 
5 
 
Neutrons 10 keV - 100 keV 
 
10 
 
Neutrons >100 keV - 2 MeV 
 
20 
 
Neutrons >2 MeV - 20 MeV 
 
10 
 
Neutrons >20 MeV 
 
5 
 
Alpha particles, fission fragments, heavy ions
 
20 
 
 
The ICRP has proposed (24) that the weighting factor for protons should be 
reduced from a value of 5 (as recommended in ICRP Publication 60, 1991) to 
a value of 2.  
The weighting factor for neutrons depends upon the energy of the incident 
neutrons. ICRP Publication 92 proposes that the means of computation of the 
factor should be a continuous function of energy rather than the step function 
given in Publication 60 (24). 
These proposals are based on current knowledge of biophysics and 
radiobiology, and acknowledge that judgments about these factors may 
change from time to time. 
[ICRP recommends that no attempt be made to retrospectively correct 
individual historical estimates of effective dose or equivalent dose in a single 
tissue or organ. Rather the revised weighting factor should be applied from 
the date of adoption.] 
 
 
Radiation Units of Measurement 
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The standard unit of radioactivity is the Becquerel (Bq), which is defined as 
the decay of one nucleus per second. 
When considering cosmic radiation the practical interest is in the biological 
effect of a radiation dose, the dose equivalent being measured in Sievert (Sv). 
The ICRP has recommended a number of quantities based on weighting 
absorbed dose, to take account of the RBE of different types of radiation. 
Dose equivalent (Sv) is one of these. 
Dose equivalent (H) is defined as 
H(LET) = Q(LET) x D(LET) 
where Q is the quality factor and is a function of LET, and D is the absorbed 
dose. 
The effective dose is obtained by the use of absorbed dose, D, along with 
different weighting factors for organs and tissues. 
Doses of cosmic radiation are of such a level that values are usually quoted in 
micro-Sievert (µSv) per hour or milli-Sievert (mSv) per year (1mSv = 
1000µSv). 
The Sievert has superseded the rem as the unit of measurement of effective 
dose [1Sv = 100rem, 1mSv = 100mrem, 1µSv = 0.1mrem]. 
 
Other Terrestrial Sources of Ionising Radiation 
There is a constant background flux of ionising radiation at ground level. 
Terrestrial background radiation from the earth’s materials contributes 2.6 
mSv per annum in the United Kingdom and 3 mSv per annum in the USA 
(58). This flux is dominated by the low-LET component (93%).  
Inhaled radon gas contributes around 2 mSv per annum to the total overall 
background ionising radiation level (58). 
 
Medical X-rays are delivered in a concentrated localised manner, and usual 
doses are of the order (58):   
 
 Chest X-ray  0.1 mSv (100 μSv) 
 Body CT scan 10 mSv 
 Chest CT scan 8 mSv 
 IVP    1.6 mSv 
 Mammogram  0.7 mSv (700 μSv) 
These are effective doses averaged over the entire body, accounting for the 
relative sensitivities of the different tissues exposed. 
 
Doses received from radiotherapy for cancer treatment range from 20 to 80 
Sv (31). 
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These are all average figures with wide individual variations. 
 
Radiological Protection 
Workers in the nuclear industry and those who work with medical X-rays may 
be designated as ‘classified workers’ and have their occupational radiation 
exposure monitored and recorded. For classified workers, the International 
Commission on Radiological Protection (ICRP) recommends maximum mean 
body effective dose limits of 20mSv per year (averaged over 5 years, with a 
maximum in any one year of 50mSv), with an additional recommendation that 
the equivalent dose to the foetus should not exceed 1mSv during the declared 
term of the pregnancy. This limit for the foetus is in line with the ICRP 
recommendation that the limit for the general public should be 1mSv per year 
(25). 
Workers in the nuclear industry and in medical physics are at potential risk of 
accidental high exposure, and radiological protection regulations require that 
they be educated to take every effort to avoid such accidents. The situation 
differs in the aerospace environment where exposure to radiation is not the 
result of an accident and is unavoidable. 
In the UK, the National Radiological Protection Board (NRPB) recommends 
that a record should be kept of exposure rates and there should be a 
systematic assessment of the individual dose of any worker considered likely 
to receive an effective dose of more than 6mSv per year, this being referred to 
as the control level. This value is a cautious arbitrary figure, representing 3/10 
of the annual maximum for classified workers and has no radiobiological 
significance (10). 
 In 1991 the ICRP recommended that exposure of flight crew members to 
cosmic radiation in jet aircraft should be considered part of occupational 
exposure to ionising radiation (25).  
In 1994 the Federal Aviation Administration (FAA) of the USA formally 
recognised that air carrier aircrews are occupationally exposed to ionising 
radiation, and recommended that they be informed about their radiation 
exposure and associated health risks and that they be assisted in making 
informed decisions with regard to their work environment (15). The FAA 
subsequently issued a technical report in October 2003 advising aircrew 
about their occupational exposure to ionising radiation (16).  
The FAA recommends the limit for an aircrew member of a 5-year average 
effective dose of 20mSv per year, with no more than 50mSv in a single year 
(17). For a pregnant aircrew member starting when she reports her pregnancy 
to management, the recommended limit for the conceptus is an equivalent 
dose of 1mSv, with no more than 0.5mSv in any month (17). 
Following the ICRP recommendation, the Council of the European Union 
adopted a directive laying down safety standards for the protection of the 
health of workers and the general public against the effects of ionising 
radiation (14). Article 42, which deals with protection of aircrew, states that for 
aircrew who are liable to be subject to exposure of more than 1 mSv per 
annum appropriate measures must be taken. In particular the employer must: 
 15
• assess the exposure of the crew concerned; 
• take into account the assessed exposure when organising working 
schedules with a view to reducing the doses of highly exposed aircrew; 
• inform the workers concerned of the health risks their work involves; and 
• apply special protection for female aircrew during declared pregnancy. 
 
The European Directive applies the ICRP limits for occupational exposure 
(20mSv per year) and the 1mSv exposure limit to the foetus for the duration of 
declared pregnancy. In addition, the European Directive indicates that 
radiation exposure to a pregnant crew member should be ‘as low as 
reasonably achievable’ (ALARA) (14). 
This was transformed into national law of the EU member states in May 2000. 
 
Both the European Directive and the FAA Technical Report follow the ICRP 
recommended limits for occupational exposure, but there are differences for 
pregnancy. The European Directive uses the ‘ALARA’ principle in 
recommending that radiation exposure to the pregnant worker should be as 
low as reasonably achievable, with an absolute maximum of 1mSv. However, 
the FAA recommends a maximum dose to the foetus of 1mSV but allows 
0.5mSv in any month, making no reference to ALARA. 
 
Maximum mean effective dose limits are summarised in Table 3. 
Table 3 
 ICRP EU FAA 
General Public 1 mSv y-1 1 mSv y-1 1 mSv y-1 
Occupationally 
exposed 
20 mSv y-1, 
5 yr average, but 
not more than 
50 mSv in 1y 
20 mSv y-1, 
5 yr average, but 
not more than 50 
mSv in 1y 
20 mSv y-1, 
5 yr average, but 
not more than 50 
mSv in 1y 
Foetus 
equivalent dose 
1 mSv y-1 1 mSv for 
declared term of 
pregnancy 
and ALARA 
1 mSV maximum, 
but 0.5 mSv in 
any month 
Control level N/a 6 mSv N/a 
 
 
Health Risks of Cosmic Radiation 
 
1. Development of cancer. 
A cell may become cancerous as a result of being irradiated, the likelihood 
being dependent upon the energy and the dose received. For an 
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accumulated cosmic radiation dose of 5 mSv per year over a career span 
of 20 years (a typical prediction for a long haul crew member), the 
likelihood of developing cancer will be 0.4% (16, 18). The overall risk of 
cancer death in the western population is 23%, so the cosmic radiation 
exposure increases the risk of cancer death from 23% to 23.4% (16, 18). 
For a career span of 30 years, the cancer risk increases from 23% to 
23.6%. 
 
2. Genetic risk. 
A child conceived after exposure of a parent to ionising radiation is at risk 
of inheriting radiation-induced genetic defects. These may take the form of 
anatomical or functional abnormalities apparent at birth or later in life. The 
risk following an accumulated dose of 5 mSv per year over a career span 
of 20 years will be 1 in 2,510 (16). For a 30-year career, the risk increases 
to 1 in 1,700. Again this needs to be considered against a background 
incidence in the general western population of approximately 1 in 51 for 
genetic abnormalities, with 2 – 3% of liveborn children having one or more 
severe abnormalities at birth (16). 
 
3. Risk to the health of the foetus. 
The risks to the foetus from ionising radiation are cancer and mental 
retardation. There is a background rate of around 1 in 39,000 for neonatal 
lymphoblastic leukaemia and 1 in 170 for childhood mental retardation 
within the general population. It is estimated that exposure of the foetus to 
cosmic radiation for 80 block hours per month will increase the risk by 
between 1 in 6,000 and 1 in 30,000 depending on the routes flown. The 
increased lifetime risk of fatal cancer from 1 mSv received during prenatal 
development is 1 in 10,000 (0.01%) (16). 
 
4. Non-cancer Effects (Degenerative Tissue Risks) 
The most important of the non-cancer risks due to radiation exposure are 
degenerative diseases including heart and digestive diseases, early and 
late effects in the central nervous system, and cataracts. Non-cancer 
effects are thought to be deterministic in nature, occurring only above a 
dose threshold well above aviation doses and most space missions, 
except for a Mars mission or extraterrestrial exposure to a large SPE. 
However, recent epidemiological studies (66, 67)  indicate threshold 
concepts do not seem to hold indicating these risks are a concern for 
spaceflight.  
 
Part Three 
 
Measurement of Cosmic Radiation Doses in Aviation 
The ICRP 1991 recommendations require that cosmic radiation exposure for 
flight crew members should be assessed and recorded (25). 
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It has been seen that the galactic cosmic radiation field at aircraft operating 
altitudes is complex, with a large energy range and the presence of all particle 
types.  
The Concorde supersonic transport aircraft first flew in 1969 and entered 
service with Air France and British Airways in 1976, retiring in 2003. From the 
outset it was appreciated that cosmic radiation (both galactic and solar) could 
present a hazard at the operating altitude of around 60,000 ft (18km). 
Accordingly, ionising radiation monitoring equipment was permanently 
installed in all Concordes and much data were derived (1, 2, 9, 11, 38). 
The introduction of aircraft such as the Boeing 747-400 and the Airbus A330 
and A340, has led to the development of ultra-longhaul flights of up to 18 
hours duration with the potential for even longer flight times. Many of the 
routes flown are trans-Polar or trans-Siberian, where geomagnetic and, to a 
lesser extent, atmospheric shielding from GCR are less than for routes at 
lower latitudes. 
Galactic cosmic radiation can be measured actively or passively. Many 
detectors measure only one type of radiation accurately and usually for only a 
limited energy range, but they may show some sensitivity to other types of 
radiation.  
An active direct reading instrument displays the appropriate values 
immediately or after a short delay, whereas passive integrating instruments 
need to be evaluated in a laboratory after the flight.  
A number of studies have been published giving effective dose rates for sub-
sonic flights, measured both actively and passively (1, 2, 4, 18, 28, 32, 33, 43, 
48, 50, 51).  These values are discussed in the next section. 
Effective dose is not directly measurable, but measured operational quantity 
(ambient dose equivalent) – do you agree with parentheses? Or how else can 
these multiple nouns be clarified? - OK can be a good estimator of the 
effective dose received from cosmic radiation. (See ‘Radiation Units of 
Measurement’, above)  Calculations of ambient dose equivalent rate or route 
doses can be validated by direct measurement.  
 
Concorde was the only commercial aircraft to be equipped with radiation 
dosimeters measuring data for the duration of every flight. Based on data 
derived from these measurements, cost-benefit analysis makes it difficult to 
justify the cost of installation, calibration and maintenance for such equipment 
in the worldwide fleet of subsonic aircraft. 
It is frequently suggested that individual dosimeters in the form of film badges 
should be worn by crew members. However, the sensitivity of such passive 
dosimeters is very low and the badges would have to be worn for several 
sectors for meaningful data to become available. Lantos et al report that 
during an experiment involving voluntary crew members wearing personal 
dosimeters, 8% of the badges were lost or not used and 2% had received 
additional X-rays during baggage security screening (30). The logistical costs 
of issuing, tracking and processing many thousands of film badges within a 
commercial airline operation are prohibitive. 
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Computer programs have been developed for the calculation of effective dose 
from galactic cosmic radiation, taking account of  
• geographic coordinates of origin and destination airports 
• longitude and latitude of all points of the aircraft’s track 
• altitude at all times of the flight 
• helicocentric potential, to account for solar activity 
• date and time of flight 
• quality of the radiation field through which the aircraft flies. 
 
The most widely used program is CARI-6, developed by the US FAA based 
on the LUIN transport code (36). It is limited to the galactic cosmic ray 
component, which is isotropic and of constant spectrum outside of the 
heliosphere. The CARI program has been validated by in-flight measurement 
and found to be accurate to within about + or - 7% (30). However, other 
workers question this accuracy because of uncertainty of the contribution of 
solar particles. There is a freely available interactive version of CARI-6, which 
runs on the Internet and is accessed via 
<http://www.cami.jccbi.gov/radiation.html>. There is also a more sophisticated 
downloadable version, which allows the user to store and process multiple 
flight profiles and to calculate dose rates at user-specified locations in the 
atmosphere. 
 
Another package, EPCARD (European Programme Package for the 
Calculation of Aviation Route Doses), has been developed on behalf of the 
European Commission (49). This is based on the FLUKA transport code (45) 
and again is limited to the galactic cosmic ray component, which is isotropic 
and of constant spectrum outside of the heliosphere. 
 
A further program is the SIEVERT system (Systeme d’Information et 
d’Evaluation par Vol de l’Exposition au Rayonnement cosmique dans les 
Transport aeriens) which has been developed on behalf of the French 
Aviation Administration (DGAC) (30). This program is freely available via 
<http://sievert-system.org>. 
 
A similar validated Canadian program is known as PCAIRE and is freely 
available from www.pcaire.com (32) 
 
These computer programs allow airline companies and their employees to 
comply with the ICRP recommendations to monitor radiation exposure. 
European airlines have a statutory duty to comply with the ICRP 
recommendations as a result of the European Union Directive (see above). 
However, elsewhere in the world there is no legal requirement for airlines to 
follow the ICRP recommendation. 
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Cosmic Radiation Doses Received by Aircraft Occupants 
There have been many studies of cosmic radiation dose rates both in 
Concorde and subsonic aircraft (1, 2, 4, 18, 22, 28, 32, 33, 43, 48-51), all 
giving similar results. European airlines have been required to monitor and 
record occupational exposure since May 2000 to comply with the European 
Directive. This is achieved using a computer program such as CARI, 
EPCARD, SIEVERT or PCAIRE, periodically validated by on-board 
measurement of the radiation field. 
Exposure depends on the route, altitude and aircraft type (which influences 
rate of climb and descent) and is usually quoted as microSievert (μSv) per 
block hour (block hours are based on the time from when the aircraft first 
moves under its own power to the time of engine shut-down at the end of the 
flight). Short haul operations tend to fly at lower altitudes than long haul, 
gaining the benefit of atmospheric shielding as well as a shorter duration of 
exposure. Conversely, many long-haul routes are flown at higher latitudes as 
well as at higher altitudes. 
 
For operations in the northern hemisphere, mean ambient equivalent dose 
rates have been measured in the region of: 
• Concorde: 12 -15 µSv per hour 
• Long-haul: 4 – 5 µSv per hour 
• Short-haul: 1 – 3 µSv per hour. 
 
In general, for UK-based crew members operating to the maximum flight time 
limitations of 900 hours per year, it is calculated that: 
• Long-haul crew have an annual mean effective exposure of 2 – 4 mSv 
per year, ie less than one fifth of the ICRP recommended dose limit; 
• Short-haul crew have an annual mean effective exposure of 1 – 2 mSv 
per year, ie less than one tenth of the recommended dose limit. 
 
On the worst-case UK high latitude polar routes, such as London Heathrow to 
Tokyo Narita, the mean ambient equivalent dose rate has been measured at 6 
µSv per hour (4). For a crew member flying 900 hours per year only on this 
route, the annual exposure would be in the region of 5.4 mSv, ie less than 
three tenths of the ICRP recommended dose limit of 20 mSv. 
For ultra-long range airline operations (arbitrarily defined as sector lengths in 
excess of 18 hours), recent studies (22) have shown a mean effective sector 
exposure of 80 μSv on the Dubai to Los Angeles route. A crew member flying 
3 return trips per month would accrue an annual exposure of 5.76 mSv. 
The FAA has calculated the worst case USA high altitude, high latitude long-
haul flight to be New York to Athens, with an equivalent dose of 6.3 µSv per 
hour (16) 
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For a pregnant crew member working on this worst-case route, she could 
work 79 block hours each month without the dose to the conceptus exceeding 
the FAA monthly-recommended limit of 0.5 mSv (0.5/0.0063 = 79). 
She could work 2 months without the dose to the conceptus exceeding the 
recommended pregnancy limit of 1 mSv (1/0.5 = 2). 
 
A number of airlines require crew members to cease flying on declaration of 
pregnancy, in conformity with the European Directive requirement for the 
radiation exposure to the foetus to be as low as reasonably achievable (3).  
The policy of the USA Federal Aviation Administration is that crew members 
must be provided with information about cosmic radiation, but there is no 
statutory requirement for them to stop flying. 
For passengers, the ICRP limit for the general public of 1 mSv per year would 
have equated to about 100 hours flying per year on Concorde, and equates to 
about 200 hours per year on trans-Equatorial subsonic routes (11). 
There are essentially two types of airline passenger – the occasional social 
traveller and the frequent business traveller. The public limit of 1 mSv per year 
will be of no consequence to the former, but could be of significance to the 
frequent business traveller who would exceed the 1 mSv limit if flying more 
than 8 transatlantic or 5 UK-Antipodean return subsonic journeys per year 
(11). However, business travellers are exposed to radiation as an essential 
part of their occupation and it is logical to apply the occupational limit of 20 
mSv to this group. This view has the support of the ICRP (6). Although 
business travellers may exceed the doses for aircrew, there is no mechanism 
in place to monitor or control their exposure. 
 
Epidemiology of Commercial Aircraft Crew Members 
The annual aircrew dose of cosmic radiation is a relatively low level of overall 
exposure, with the maximum being no more than 2 or 3 times the annual level 
of exposure to background radiation at ground level. There have been a 
number of epidemiological surveys of cancer mortality and incidence in 
commercial flight crew members over the years, which have reported small 
excesses of a variety of cancers. However the results have lacked 
consistency. 
This lack of consistency mainly derives from the small size of cohorts 
examined and the lack of data on exposure and confounding factors that 
might explain the findings. 
In Europe two large mortality cohort studies, one amongst flight deck crew (8) 
and one amongst cabin crew (57), together with a large cancer incidence 
study amongst Nordic pilots (39) have been published. They are based on 
data from many of the individual studies in the literature but contain additional 
data, providing increased statistical power in looking at small excesses, allow 
measures of consistency between studies to be determined, and provide the 
basis for dose-response assessments. 
Both the Blettner et al paper (8), which looked at 28,000 flight deck crew with 
591,584 person years at risk, and the Pukkala et al paper (39), comprising 
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177,000 person years at risk from 10,211 pilots, concluded that occupational 
risk factors were of limited influence on the findings. Was there a mean or 
average period of observation, or person-years?? – Person years are quoted! 
There was consistency though in the mortality study showing an excess of 
malignant melanoma. In the incidence study, this excess referred to both 
malignant melanoma and other forms of skin cancer as well. Blettner 
concluded that the excess melanoma incidence may be attributable to 
ultraviolet radiation, perhaps due to leisure-time sun exposure, but more work 
is required. 
Pukkala et al (39) concluded that although the risk of melanoma increased 
with estimated dose of ionizing radiation, the excess may well be attributable 
to solar ultra-violet radiation. 
In the study by Zeeb et al (57), the excess mortality from malignant melanoma 
was restricted to male cabin crew members. 
 
Several studies in the last decade have suggested a small excess of breast 
cancer amongst female flight attendants (cabin crew). However, the 
interpretation has been hampered by sample size and lack of detailed 
information on confounding factors. 
In an attempt to unify the findings, the study by Zeeb et al (57) examined data 
from eight European countries. Mortality patterns among more than 51,000 
airline cabin crew members were investigated, yielding approximately 659,000 
person-years of follow-up. Among female cabin crew, overall mortality and all-
cancer mortality were slightly reduced, while breast cancer mortality was 
slightly but non-significantly increased.  
The authors concluded that ionising radiation could contribute in a small way 
to an excess risk of breast cancer among cabin crew, but the association may 
be confounded by differences in reproductive factors or other lifestyle factors, 
such as circadian rhythm disruption. 
 
A study by Raffnson et al in 2003 based on 35 cases of breast cancer (42), for 
which more detailed information on reproductive history is available, 
attempted to further identify the relative contribution of occupation to the 
excess seen in their earlier cohort study (40).  
When the results are examined the risk is seen to be significantly increased 
only during the period prior to 1971, when cosmic radiation doses would have 
been lower due to altitude considerations. No excess is seen in the period 
after 1971 showing the difficulty of disentangling the contribution of cosmic 
radiation to the aetiology of breast cancer 
Overall the conclusion from Zeeb et al (57) was that among airline cabin crew 
in Europe, there was no increase in mortality that could be attributed to 
cosmic radiation or other occupational exposures to any substantial extent. 
 
A population-based case-controlled study from Iceland published by Raffnson 
et al in 2005 (41) concluded that the association between the cosmic radiation 
exposure of pilots and the risk of developing eye nuclear cataracts, adjusted 
 22
for age, smoking status, and sunbathing habits, indicates that cosmic 
radiation may be a causative factor in nuclear cataracts among commercial 
airline pilots. However the study fails to address the variability in objective 
assessment of cataracts and the possibility of observer bias. 
 
A report by Stern from the German Center of Aerospace in 2006 (52) 
concluded that the occurrence of cataract surgery amongst their pilot 
population is smaller than in the normal population, with no cases of pilots 
having to undergo cataract surgery during their career (other than one case of 
traumatic cataract). Similar findings are reported by the UK CAA (personal 
communication, 2007). 
Any association between exposure of airline pilots to cosmic radiation and the 
development of cataracts would appear to be weak. 
 
Conclusion for Commercial Aircraft Travellers 
Whilst it is known that there is no level of ionising radiation exposure below 
which effects do not occur, the evidence so far indicates that the probability of 
airline crew members or passengers suffering any abnormality or disease as 
a result of exposure to cosmic radiation is very low. 
Epidemiological studies of flight deck crew and cabin crew have so far not 
shown any increase in cancer mortality or cancer incidence that could be 
directly attributable to ionising radiation exposure.  
However, individual mortality studies and combined analyses have shown an 
excess of malignant melanoma. Separate and combined analyses of cancer 
incidence have shown an excess for malignant melanoma and for other skin 
cancers. Many authors believe the findings can be explained by exposure to 
ultraviolet light. Some others believe that the influence of cosmic radiation 
cannot be entirely excluded, although no plausible pathological mechanism 
has been identified 
With respect to the suggestion that cabin crew may be at a higher risk of 
contracting breast cancer than those females in a non-flying occupation, it is 
very difficult to effectively disentangle the relative contributions of 
occupational, reproductive and other factors associated with breast cancer 
using the data currently available. 
Similarly when considering the reported association between cosmic radiation 
and eye cataracts, it is difficult to exclude observer bias and the influence of 
sunlight, smoking, dehydration and diet associated with the protein structure 
changes in the lens associated with age.  
The European Union has in place a legislative framework for assessing the 
cosmic radiation exposure for airline crew members, which appears to be 
effective. Other jurisdictions, such as the USA, rely on advisory material and 
educational programmes. There is a need to improve worldwide consistency, 
accuracy of calculations, measurements and allowance for, and avoidance of, 
solar particle events. 
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Part Four 
 
In considering dose limits for astronauts working, it is useful to consider 
historical recommendations that NASA has received from external advisory 
committees, which have formed the basis for dose limits. Recommendations 
by the National Academy of Sciences (NAS) in 1967 (68) noted that radiation 
protection in manned space flight is philosophically distinct from protection 
practices of terrestrial workers because of the high-risk nature of space 
missions. The report of the National Academy of Sciences from 1967 did not 
recommend “permissible doses” for space operations, noting the possibility 
that such limits may place the mission in jeopardy and instead made 
estimates of what the likely effects would be for a given dose of radiation.  In 
1970, the NAS Space Science Board (69) made recommendations of 
guidelines for career doses to be used by NASA for long-term mission design 
and manned operations. At that time, NASA employed only male astronauts 
and the typical age of astronauts was 30-40 years. A “primary reference risk” 
was proposed equal to the natural probability of cancer over a period of 20-
years following the radiation exposure (using the period from 35 to 55 years of 
age) and was essentially a doubling dose. The estimated doubling dose of 
382 rem (3.82 Sv), which ignored an dose-rate reduction factor was rounded, 
to 400 rem (4 Sv). The NAS panel noted that their recommendations were not 
risk limits, but rather a reference risk and that higher risk could be considered 
for planetary missions or a lower level of risk for a possible space station (69). 
Ancillary reference risks were described to consider monthly, annual, and 
career exposure patterns. However, the NAS recommendations were 
implemented by NASA as dose limits used operationally for all missions until 
1989. 
At the time of the 1970 NAS report the major risk from radiation was believed 
to be leukemia. Since that time the maturation of the data from the Japanese 
atomic bomb (AB) survivors has led to estimates of higher levels of cancer 
risk for a given dose of radiation including the observation that the risk of solid 
tumors following radiation exposure occurs with a higher probability than 
leukemias although with a longer latency period before expression. Along with 
the maturation of the AB data, re-evaluation of the dosimetry of the AB 
survivors, scientific assessments of the dose response models, and dose-rate 
dependencies have contributed to the large increase in the risk estimate over 
this time period (1970-1997). The possibility of future changes in risk 
estimates can of course not be safely predicted today. Thus protection against 
uncertainties is an ancillary condition to the ALARA principle, suggesting 
conservatism as workers approach dose limits. 
By the early 1980’s several major changes had occurred leading to the need 
for a new approach to define dose limits for astronauts. At that time NASA 
requested the National Council on Radiation Protection and Measurements 
(NCRP) to re-evaluate dose limits to be used for low Earth orbit (LEO) 
operations. Considerations included the increases in estimates of radiation-
induced cancer risks, the criteria for risk limits, and the role of the evolving 
makeup of the astronaut population from male test pilots to a larger diverse 
population (~100) astronauts including mission specialists,  female astronauts, 
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and career astronauts of higher ages that often participate in several 
missions. In 1989, the NCRP Report No. 98 (70) recommended age and 
gender dependent career dose limits using a 3% increase in cancer mortality 
as a common risk limit. The limiting level of 3% excess cancer fatality risk was 
based on several criteria including comparison to dose limits for ground 
radiation workers and to rates of occupational death in the less-safe 
industries. It was noted that astronauts face many other risks, and adding an 
overly large radiation risk was not justified. It also is noted that the average 
years of life loss from radiation induced cancer death, about 15 years for 
workers over age 40-y, and 20 years for workers between 20-40 y, is less 
than that of other occupational injuries. A comparison of radiation-induced 
cancer deaths to cancer fatalities in the US population is also complex 
because the smaller years of life loss in the general population where most 
cancer deaths occurring above age 70-y. 
In the 1990’s, the additional follow-up and evaluation of the AB survivor data 
has led to further reductions in the estimated cancer risk for a given dose of 
radiation.  The 2000 recommendations from NCRP (71), while keeping the 
basic philosophy of risk limitation in their earlier report, advocate significantly 
lower limits than those recommended in 1989 (70). Table-4 lists examples of 
career radiation limits for a career duration of 10 years with the doses 
assumed to be spread evenly over a career. The values from the previous 
report are also listed for comparison. Both of these reports specify that these 
limits do not apply to exploration missions because of the large uncertainties 
in predicting the risks of late effects from heavy ions.  
The NCRP Report No. 132 (71) notes that the use of comparisons to fatalities 
in the less-safe industries advocated by the NCRP in 1989, was no longer 
viable because of the large improvements made in ground-based 
occupational safety.  
 
Table-4. Career dose limits (in Sv) corresponding to 3% excess cancer 
mortality for 10-year careers as a function of age and sex as recommended 
by the National Council on Radiation Protection and Measurements (NCRP, 
1989 and NCRP, 2000). 
  
 
NCRP Report No. 98 NCRP Report No. 132 
Age, yr Male Female Male Female 
25 1.5 Sv 1.0 Sv 0.7 Sv 0.4 Sv 
35 2.5 1.75 1.0 0.6 
45 3.2 2.5 1.5 0.9 
55 4.0 3.0 3.0 1.7 
 
The decreased rate of fatalities in the so-called less safe industries, such as 
mining and agriculture, would suggest a limit below the 3% fatality level today 
compared to the 1989. The most recent reviews of the acceptable levels of 
 25
radiation risk for LEO (71), instead advocate that comparisons to career dose 
limits for ground-based workers be used. It is also widely held that the social 
and scientific benefits of space flight continue to provide justification for the 
3% risk level for astronauts participating in LEO missions.  
Risk projection models serve several roles (72, 73); these roles include setting 
dose-to-risk conversion factors needed to define dose limits, projecting 
mission risks, and evaluating the effectiveness of shielding or other 
countermeasures. For mission planning and operations, NASA uses the 
model recommended in the NCRP Report No. 132 for estimating cancer risks 
from space (71). This model, which is similar to approaches described by other 
radiation risk assessment committees or in the scientific literature, employs a 
life-table formalism, epidemiological assessments of excess risk in exposed 
cohorts such as the atomic-bomb survivors, and estimates of dose and dose-
rate reduction factors (DDREFs) and linear energy transfer (LET)-dependent 
radiation quality factors. 
Recently, NASA recognized that projecting uncertainties in cancer risk 
estimates along with point estimates should be a requirement for ensuring 
mission safety, because point estimates alone have limited value when the 
uncertainties in the factors that enter into risk calculations are large. Estimates 
of 95% confidence intervals (CI) for various radiation protection scenarios are 
meaningful additions to the traditional point estimates, and can be used to 
explore the value of mitigation approaches and of research that could narrow 
the various factors that enter into risk calculations. 
Uncertainties for low-LET radiation, such as gamma-rays, have been 
reviewed several times in recent years, and indicate that the major uncertainty 
is the extrapolation of cancer effects data from high to low doses and dose-
rates (74, 75). Other uncertainties include the transfer of risk across 
populations and sources of error in epidemiology data including dosimetry, 
bias, and statistical limitations. For low-LET radiation, probability distribution 
functions (PDFs) were described previously (73) and indicate upper 95% 
confidence intervals about 2 times higher than the median risk estimate used 
in ground based radiation protection. 
In estimating cancer risks for space radiation, additional uncertainties occur 
related to estimating the biological effectiveness of protons and heavy ions, 
and to predicting LET spectra at tissue sites (71, 72). The limited 
understanding of heavy ion radiobiology has been estimated to be the largest 
contributor to the uncertainty for space radiation effects (73), and radiation 
quality factors are found to contribute the major portion of the uncertainties. 
For space radiation upper 95% confidence levels are estimated to be about 4 
times higher than the median estimate for GCR, and 3 times higher for proton 
exposures from a solar particle event. (include a table/graph to illustrate?? 
 
Space Dosimetry 
 
The use of radiation weighting factors is not used directly at NASA, and 
instead individual organ dose and dose equivalents are estimated for each 
astronaut using an approach that relies on available flight dosimetry and 
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transport models of space vehicles and the human body. In this approach 
radiation weighting factors are replaced by LET dependent radiation quality 
factors and the attenuation of space radiation by the tissue is described (71). 
The main source of passive dosimetry data are thermoluminescence 
dosimeters (TLD) that are worn by each astronaut during his or her mission. 
In some cases CR-39 plastic track detectors have been included in the 
passive dosimetry packages (76). Additional information is obtained by TLD’s 
that are mounted throughout space vehicles such at the space shuttle, space 
station Mir, and the International Space Station (ISS) to survey the variation of 
point dose dependencies from shielding variations (76).  
 
Tissue equivalent proportional counters (TEPC’s) have been flown on some 
space shuttle missions (77) and on the Mir and ISS. TEPC’s (shown in Figure 
3) are a relative small devise weighing less than 1 kg that provide time 
dependent data and a method to estimate the individual contributions from the 
GCR and trapped proton doses because of the strong geographical 
dependence of the trapped protons (77, 78) in low Earth orbit. TEPC data can 
be used to validate models used to predict organ dose equivalents when 
models of TEPC response functions are coupled to space transport models, 
albeit not for a direct measurement of mission quality factors. It is estimated 
that a combined approach using crew dosimetry worn on the surface of the 
body, and radiation transport codes to estimate individual organ doses are 
able to describe organ dose equivalents with standard errors of less than 
10%. Results of this approach for past space missions are shown in Figure 4.  
 
Figure 3. The Tissue Equivalent Proportional Counter (TEPC) is an automatic 
microdosimetry system, which consists of a spectrometer unit and a detector 
unit. The spectrometer unit contains a computer that allows real-time analysis 
of the data and provides data on the dose equivalent rate as a function of 
lineal energy (y) and time for space radiation. The TEPC is filled with a low 
pressure gas. TEPC’s are also used in aviation. 
 
 
 
 
Figure 4. The badge doses and effective doses versus calendar year from all 
astronauts on all NASA space missions (Mercury, Gemini, Apollo, Skylab, 
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Apollo-Soyuz, Shuttle, Mir, and ISS (Expedition 1-10)) updated from Cucinotta 
et al. (79). 
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Long-term missions on the ISS or the Russian Mir space station 
have led to crew exposures that exceed 100 mSv. For future 
missions to Mars, exposures approaching 1000 mSv or more can be 
expected. Table 5 shows projections for effective doses, Risk of 
exposure induced death (REID) due to fatal cancer, and 95% 
confidence levels for 40-y males and females for several deep space 
mission scenarios.  Because these risks will be much higher levels 
than past space missions or ground-based exposures, studies to 
improve the understanding of the biological effects of space radiation 
and to develop successful mitigation measures are a primary focus 
of NASA and other space agencies.
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Table 5. Calculations of effective doses,%-Risk of Exposue Induced Death 
(REID) from fatal cancer, and 95% confidence intervals (CI) for lunar or 
Mars missions. Calculations are at solar minimum where GCR dose is the 
highest behind a 5-g/cmP2P aluminum shield. The absorbed dose, D and 
Effective dose, E are averaged over tissues prominent for cancer risks. 
Competing causes of death are considered in the calculation because for 
high values of risk they compress the risk probabilities (>5%) (72). 
 
Exploration mission 
(length of mission) 
D, Gy E, Sv %-REID 95% CI 
 Males (40 y) 
Lunar (180 d) 0.06 0.17 0.68 [0.20, 2.4] 
Mars swingby (600 d) 0.37 1.03 4.0 [1.0, 13.5] 
Mars exploration (1000 d) 0.42 1.07 4.2 [1.3, 13.6] 
 Females (40 y) 
Lunar (180 d) 0.06 0.17 0.82 [0.24, 3.0] 
Mars swingby (600 d) 0.37 1.03 4.9 [1.4, 16.2] 
Mars exploration (1000 d) 0.42 1.07 5.1 [1.6, 16.4] 
 
   
 
Radiation shielding can be shown to be cost effective for protection against 
solar particle events (SPE). In deep space or on the surface of the moon 
about 20 g/cm2 of aluminium equivalent material will reduce effective doses 
from majority of the SPE to well below radiation limits. Materials with high 
hydrogen content such as polyethylene are the most effective in reducing 
effective doses leading to a significantly reduced mass allotment for radiation 
shieding compared to traditional spacecraft materials such as aluminium (56, 
80). The higher energies of GCR compared to solar protons makes shielding 
an inadequate mitigation approach. Effective doses attenuate quite slowly and 
the amount of shielding needed can be prohibitive. At the present time 
reducing the uncertainties in models of radiation health risk such as 
carcinogenesis is a focus and is expected to lead to viable biological 
countermeasure approaches. By elucidating the biological mechanisms that 
cause radiation cancer, including different mechanisms of action between 
terrestrial and space radiation types, approaches to intervene and reduce risk 
are expected to emerge. These studies should be of value for aviation 
radiation protection as well.  
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